Role of vitamin D in cardiovascular health

American Journal of Cardiology

Volumn 106, Issue 6, 2010, Pages 798-805

  Reddy Vanga, Subba ^a   Good, Mathew ^a   Howard, Patricia A ^b   Vacek, James L ^a  

^a UNIVERSITY OF KANSAS HOSPITAL   (United States)

^b UNIVERSITY OF KANSAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,25 DIHYDROXYERGOCALCIFEROL; 22,23 DIHYDROERGOCALCIFEROL; 25 HYDROXYCHOLESTEROL; 25 HYDROXYERGOCALCIFEROL; ANTIHYPERTENSIVE AGENT; CALCIUM; COLECALCIFEROL; ERGOCALCIFEROL; LOOP DIURETIC AGENT; PARATHYROID HORMONE; SITOCALCIFEROL; UNCLASSIFIED DRUG; VITAMIN D; VITAMIN D RECEPTOR; BONE DENSITY CONSERVATION AGENT;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; GENE MUTATION; HEART ARRHYTHMIA; HEART FAILURE; HUMAN; HYPERTENSION; KIDNEY DISEASE; LIPID METABOLISM; LIVER DISEASE; OBESITY; PARATHYROID HORMONE BLOOD LEVEL; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SKIN COLOR; SMOKING; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN D INTOXICATION; VITAMIN METABOLISM; VITAMIN SUPPLEMENTATION; ARRHYTHMIAS, CARDIAC; BONE; CARDIOVASCULAR DISEASES; COMPLICATION; DRUG EFFECTS; EVIDENCE BASED MEDICINE; METABOLISM; MYOCARDIAL INFARCTION; NUTRITIONAL REQUIREMENT; PATHOPHYSIOLOGY; TREATMENT OUTCOME; VASCULAR ENDOTHELIUM;

ARRHYTHMIAS, CARDIAC; BONE AND BONES; BONE DENSITY CONSERVATION AGENTS; CARDIOVASCULAR DISEASES; CORONARY ARTERY DISEASE; ENDOTHELIUM, VASCULAR; EVIDENCE-BASED MEDICINE; HUMANS; MYOCARDIAL INFARCTION; NUTRITIONAL REQUIREMENTS; RISK FACTORS; TREATMENT OUTCOME; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 77956338895     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2010.04.042     Document Type: Review

References (100)

1. H.F. DeLuca Overview of general physiologic features and functions of vitamin D Am J Clin Nutr 80 2004 1689S 1696S
2. K.A. Nibbelink, D.X. Tishkoff, S.D. Hershey, A. Rahman, and R.U. Simpson 1,25(OH)2-vitamin D3 actions on cell proliferation, size, gene expression, and receptor localization, in the HL-1 cardiac myocyte J Steroid Biochem Mol Biol 103 2007 533 537
3. S. Pilz, A. Tomaschitz, E. Ritz, and T.R. Pieber Vitamin D status and arterial hypertension: a systematic review Nat Rev Cardiol 6 2009 621 630
4. R. Vieth Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety Am J Clin Nutr 69 1999 842 856
5. M.S. Calvo, S.J. Whiting, and C.N. Barton Vitamin D fortification in the United States and Canada: current status and data needs Am J Clin Nutr 80 2004 1710S 1716S
6. D.H. Kim, S. Sabour, U.N. Sagar, S. Adams, and D.J. Whellan Prevalence of hypovitaminosis D in cardiovascular diseases (from the National Health and Nutrition Examination Survey 2001 to 2004) Am J Cardiol 102 2008 1540 1544
7. M.F. Holick Vitamin D deficiency N Engl J Med 357 2007 266 281
8. J.H. Lee, J.H. O'Keefe, D. Bell, D.D. Hensrud, and M.F. Holick Vitamin D deficiency an important, common, and easily treatable cardiovascular risk factor? J Am Coll Cardiol 52 2008 1949 1956
9. V. Tangpricha, E.N. Pearce, T.C. Chen, and M.F. Holick Vitamin D insufficiency among free-living healthy young adults Am J Med 112 2002 659 662
10. S.S. Harris, E. Soteriades, J.A. Coolidge, S. Mudgal, and B. Dawson-Hughes Vitamin D insufficiency and hyperparathyroidism in a low income, multiracial, elderly population J Clin Endocrinol Metab 85 2000 4125 4130
11. A.C. Looker, B. Dawson-Hughes, M.S. Calvo, E.W. Gunter, and N.R. Sahyoun Serum 25-hydroxyvitamin D status of adolescents and adults in two seasonal subpopulations from NHANES III Bone 30 2002 771 777
12. R.P. Heaney, K.M. Davies, T.C. Chen, M.F. Holick, and M.J. Barger-Lux Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol Am J Clin Nutr 77 2003 204 210
13. 2 is as effective as vitamin D3 in maintaining circulating concentrations of 25-hydroxyvitamin D J Clin Endocrinol Metab 93 2008 677 681
14. H.A. Bischoff-Ferrari, E. Giovannucci, W.C. Willett, T. Dietrich, and B. Dawson-Hughes Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes Am J Clin Nutr 84 2006 18 28
15. L.M. Hall, M.G. Kimlin, P.A. Aronov, B.D. Hammock, J.R. Slusser, L.R. Woodhouse, and C.B. Stephensen Vitamin D intake needed to maintain target serum 25-hydroxyvitamin D concentrations in participants with low sun exposure and dark skin pigmentation is substantially higher than current recommendations J Nutr 140 2010 542 550
16. S.A. Stechschulte, R.S. Kirsner, and D.G. Federman Vitamin D: bone and beyond, rationale and recommendations for supplementation Am J Med 122 2009 793 802
17. J.N. Hathcock, A. Shao, R. Vieth, and R. Heaney Risk assessment for vitamin D Am J Clin Nutr 85 2007 6 18
18. D.W. Stephenson, and A.N. Peiris The lack of vitamin D toxicity with megadose of daily ergocalciferol (D2) therapy: a case report and literature review South Med J 102 2009 765 768
19. 3: effects on biochemical parameters in two men Ann Clin Biochem 45 2008 106 110
20. L.M. Resnick, F.B. Muller, and J.H. Laragh Calcium-regulating hormones in essential hypertension Relation to plasma renin activity and sodium metabolism Ann Intern Med 105 1986 649 654
21. Y.C. Li, J. Kong, M. Wei, Z.F. Chen, S.Q. Liu, and L.P. Cao 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system J Clin Invest 110 2002 229 238
22. R. Krause, M. Buhring, W. Hopfenmuller, M.F. Holick, and A.M. Sharma Ultraviolet B and blood pressure Lancet 352 1998 709 710
23. E.D. Burgess, R.G. Hawkins, and M. Watanabe Interaction of 1,25-dihydroxyvitamin D and plasma renin activity in high renin essential hypertension Am J Hypertens 3 1990 903 905
24. O. Tarcin, D.G. Yavuz, B. Ozben, A. Telli, A.V. Ogunc, M. Yuksel, A. Toprak, D. Yazici, S. Sancak, O. Deyneli, and S. Akalin Effect of vitamin D deficiency and replacement on endothelial function in asymptomatic subjects J Clin Endocrinol Metab 94 2009 4023 4030
25. 3 and the peripheral circulation in moderate arterial primary hypertension Blood Press 3 1994 389 393
26. E. Kristal-Boneh, P. Froom, G. Harari, and J. Ribak Association of calcitriol and blood pressure in normotensive men Hypertension 30 1997 1289 1294
27. R. Scragg, I. Holdaway, V. Singh, P. Metcalf, J. Baker, and E. Dryson Serum 25-hydroxycholecalciferol concentration in newly detected hypertension Am J Hypertens 8 1995 429 432
28. R. Scragg, M. Sowers, and C. Bell Serum 25-hydroxyvitamin D, ethnicity, and blood pressure in the Third National Health and Nutrition Examination Survey Am J Hypertens 20 2007 713 719 (Pubitemid 46936167)
29. J.A. Sugden, J.I. Davies, M.D. Witham, A.D. Morris, and A.D. Struthers Vitamin D improves endothelial function in patients with type 2 diabetes mellitus and low vitamin D levels Diabet Med 25 2008 320 325
30. M. Pfeifer, B. Begerow, H.W. Minne, D. Nachtigall, and C. Hansen Effects of a short-term vitamin D(3) and calcium supplementation on blood pressure and parathyroid hormone levels in elderly women J Clin Endocrinol Metab 86 2001 1633 1637
31. M.D. Witham, M.A. Nadir, and A.D. Struthers Effect of vitamin D on blood pressure: a systematic review and meta-analysis J Hypertens 27 2009 1948 1954
32. M.L. Melamed, P. Muntner, E.D. Michos, J. Uribarri, C. Weber, J. Sharma, and P. Raggi Serum 25-hydroxyvitamin D levels and the prevalence of peripheral arterial disease: results from NHANES 2001 to 2004 Arterioscler Thromb Vasc Biol 28 2008 1179 1185
33. 3 concentrations and carotid artery intima-media thickness among type 2 diabetic patients Clin Endocrinol (Oxf) 65 2006 593 597 (Pubitemid 44583818)
34. J.P. Reis, E.D. Michos, D. von Muhlen, and E.R. Miller III Differences in vitamin D status as a possible contributor to the racial disparity in peripheral arterial disease Am J Clin Nutr 88 2008 1469 1477
35. A. Fahrleitner, H. Dobnig, A. Obernosterer, E. Pilger, G. Leb, K. Weber, S. Kudlacek, and B.M. Obermayer-Pietsch Vitamin D deficiency and secondary hyperparathyroidism are common complications in patients with peripheral arterial disease J Gen Intern Med 17 2002 663 669
36. A.G. Pittas, J. Lau, F.B. Hu, and B. Dawson-Hughes The role of vitamin D and calcium in type 2 diabetes A systematic review and meta-analysis J Clin Endocrinol Metab 92 2007 2017 2029 (Pubitemid 46997093)
37. R. Bland, D. Markovic, C.E. Hills, S.V. Hughes, S.L. Chan, P.E. Squires, and M. Hewison Expression of 25-hydroxyvitamin D3-1alpha-hydroxylase in pancreatic islets J Steroid Biochem Mol Biol 2004 89 90 121125
38. U. Zeitz, K. Weber, D.W. Soegiarto, E. Wolf, R. Balling, and R.G. Erben Impaired insulin secretory capacity in mice lacking a functional vitamin D receptor FASEB J 17 2003 509 511
39. P.M. Bourlon, A. Faure-Dussert, and B. Billaudel The de novo synthesis of numerous proteins is decreased during vitamin D3 deficiency and is gradually restored by 1, 25-dihydroxyvitamin D3 repletion in the islets of Langerhans of rats J Endocrinol 162 1999 101 109
40. 3 of insulin receptor expression and insulin responsiveness for glucose transport in U-937 human promonocytic cells Endocr J 47 2000 383 391
41. M. Karvonen, V. Jantti, S. Muntoni, M. Stabilini, L. Stabilini, and J. Tuomilehto Comparison of the seasonal pattern in the clinical onset of IDDM in Finland and Sardinia Diabetes Care 21 1998 1101 1109
42. S.B. Mohr, C.F. Garland, E.D. Gorham, and F.C. Garland The association between ultraviolet B irradiance, vitamin D status and incidence rates of type 1 diabetes in 51 regions worldwide Diabetologia 51 2008 1391 1398
43. The EURODIAB Substudy 2 Study Group Vitamin D supplement in early childhood and risk for Type I (insulin-dependent) diabetes mellitus Diabetologia 42 1999 51 54
44. H. Ishii, H. Suzuki, T. Baba, K. Nakamura, and T. Watanabe Seasonal variation of glycemic control in type 2 diabetic patients Diabetes Care 24 2001 1503
45. 3 on insulin secretion and peripheral insulin sensitivity in type 2 diabetic patients Int J Clin Pract 57 2003 258 261 (Pubitemid 36700706)
46. K.C. Chiu, A. Chu, V.L. Go, and M.F. Saad Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction Am J Clin Nutr 79 2004 820 825
47. 3 repletion Can Fam Physician 54 2008 864 866
48. L.A. Martini, and R.J. Wood Vitamin D status and the metabolic syndrome Nutr Rev 64 2006 479 486
49. D. Fliser, A. Stefanski, E. Franek, P. Fode, A. Gudarzi, and E. Ritz No effect of calcitriol on insulin-mediated glucose uptake in healthy subjects Eur J Clin Invest 27 1997 629 633
50. K. Tai, A.G. Need, M. Horowitz, and I.M. Chapman Glucose tolerance and vitamin D: effects of treating vitamin D deficiency Nutrition 24 2008 950 956
51. F. Dilmec, E. Uzer, F. Akkafa, E. Kose, and A.B. van Kuilenburg Detection of VDR gene ApaI and TaqI polymorphisms in patients with type 2 diabetes mellitus using PCR-RFLP method in a Turkish population J Diabetes Complications 24 2009 186 191
52. M.T. Malecki, J. Frey, D. Moczulski, T. Klupa, E. Kozek, and J. Sieradzki Vitamin D receptor gene polymorphisms and association with type 2 diabetes mellitus in a Polish population Exp Clin Endocrinol Diabetes 111 2003 505 509 (Pubitemid 38101497)
53. H.K. Bid, R. Konwar, C.G. Aggarwal, S. Gautam, M. Saxena, V.L. Nayak, and M. Banerjee Vitamin D receptor (FokI, BsmI and TaqI) gene polymorphisms and type 2 diabetes mellitus: a North Indian study Indian J Med Sci 63 2009 187 194
54. L.G. Danescu, S. Levy, and J. Levy Vitamin D and diabetes mellitus Endocrine 35 2009 11 17
55. L. Lind, A. Hanni, H. Lithell, A. Hvarfner, O.H. Sorensen, and S. Ljunghall Vitamin D is related to blood pressure and other cardiovascular risk factors in middle-aged men Am J Hypertens 8 1995 894 901
56. 3 supplementation may have adverse effects on serum lipids during postmenopausal hormone replacement therapy Eur J Endocrinol 137 1997 495 502
57. M. Montagnani, F. Lore, G. Di Cairano, S. Gonnelli, C. Ciuoli, A. Montagnani, and C. Gennari Effects of pravastatin treatment on vitamin D metabolites Clin Ther 16 1994 824 829
58. J.L. Perez-Castrillon, G. Vega, L. Abad, A. Sanz, J. Chaves, G. Hernandez, and A. Duenas Effects of atorvastatin on vitamin D levels in patients with acute ischemic heart disease Am J Cardiol 99 2007 903 905
59. H. Wilczek, J. Sobra, R. Ceska, V. Justova, Z. Juzova, R. Prochazkova, and M. Kvasilova Monitoring plasma levels of vitamin D metabolites in simvastatin (Zocor) therapy in patients with familial hypercholesterolemia [article in Czech] Cas Lek Cesk 133 1994 727 729
60. B. Yavuz, D.T. Ertugrul, H. Cil, N. Ata, K.O. Akin, A.A. Yalcin, M. Kucukazman, K. Dal, M.S. Hokkaomeroglu, B.B. Yavuz, and E. Tutal Increased levels of 25 hydroxyvitamin D and 1,25-dihydroxyvitamin D after rosuvastatin treatment: a novel pleiotropic effect of statins? Cardiovasc Drugs Ther 23 2009 295 299
61. O. Guryev, R.A. Carvalho, S. Usanov, A. Gilep, and R.W. Estabrook A pathway for the metabolism of vitamin D3: unique hydroxylated metabolites formed during catalysis with cytochrome P450scc (CYP11A1) Proc Natl Acad Sci U S A 100 2003 14754 14759
62. J. Oh, S. Weng, S.K. Felton, S. Bhandare, A. Riek, B. Butler, B.M. Proctor, M. Petty, Z. Chen, K.B. Schechtman, L. Bernal-Mizrachi, and C. Bernal-Mizrachi 1,25(OH)2 vitamin d inhibits foam cell formation and suppresses macrophage cholesterol uptake in patients with type 2 diabetes mellitus Circulation 120 2009 687 698
63. A. Zittermann, J. Fischer, S.S. Schleithoff, G. Tenderich, U. Fuchs, and R. Koerfer Patients with congestive heart failure and healthy controls differ in vitamin D-associated lifestyle factors Int J Vitam Nutr Res 77 2007 280 288
64. K.E. Watson, M.L. Abrolat, L.L. Malone, J.M. Hoeg, T. Doherty, R. Detrano, and L.L. Demer Active serum vitamin D levels are inversely correlated with coronary calcification Circulation 96 1997 1755 1760
65. A. Fleck Latitude and ischaemic heart disease Lancet 1 1989 613
66. J. Kendrick, G. Targher, G. Smits, and M. Chonchol 25-Hydroxyvitamin D deficiency is independently associated with cardiovascular disease in the Third National Health and Nutrition Examination Survey Atherosclerosis 205 2009 255 260
67. M.L. Melamed, E.D. Michos, W. Post, and B. Astor 25-hydroxyvitamin D levels and the risk of mortality in the general population Arch Intern Med 168 2008 1629 1637
68. M. Wolf, A. Shah, O. Gutierrez, E. Ankers, M. Monroy, H. Tamez, D. Steele, Y. Chang, C.A. Camargo Jr, M. Tonelli, and R. Thadhani Vitamin D levels and early mortality among incident hemodialysis patients Kidney Int 72 2007 1004 1013
69. E. Giovannucci, Y. Liu, B.W. Hollis, and E.B. Rimm 25-Hydroxyvitamin D and risk of myocardial infarction in men: a prospective study Arch Intern Med 168 2008 1174 1180
70. T.J. Wang, M.J. Pencina, S.L. Booth, P.F. Jacques, E. Ingelsson, K. Lanier, E.J. Benjamin, R.B. D'Agostino, M. Wolf, and R.S. Vasan Vitamin D deficiency and risk of cardiovascular disease Circulation 117 2008 503 511
71. S. Pilz, H. Dobnig, J.E. Fischer, B. Wellnitz, U. Seelhorst, B.O. Boehm, and W. Marz Low vitamin d levels predict stroke in patients referred to coronary angiography Stroke 39 2008 2611 2613
72. S. Pilz, W. Marz, B. Wellnitz, U. Seelhorst, A. Fahrleitner-Pammer, H.P. Dimai, B.O. Boehm, and H. Dobnig Association of vitamin D deficiency with heart failure and sudden cardiac death in a large cross-sectional study of patients referred for coronary angiography J Clin Endocrinol Metab 93 2008 3927 3935
73. A.Z. LaCroix, J. Kotchen, G. Anderson, R. Brzyski, J.A. Cauley, S.R. Cummings, M. Gass, K.C. Johnson, M. Ko, J. Larson, J.E. Manson, M.L. Stefanick, and J. Wactawski-Wende Calcium plus vitamin D supplementation and mortality in postmenopausal women: the Women's Health Initiative calcium-vitamin D randomized controlled trial J Gerontol A Biol Sci Med Sci 64 2009 559 567
74. D.P. Trivedi, R. Doll, and K.T. Khaw Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial BMJ 326 2003 469
75. D.X. Tishkoff, K.A. Nibbelink, K.H. Holmberg, L. Dandu, and R.U. Simpson Functional vitamin D receptor (VDR) in the t-tubules of cardiac myocytes: VDR knockout cardiomyocyte contractility Endocrinology 149 2008 558 564
76. R.E. Weishaar, S.N. Kim, D.E. Saunders, and R.U. Simpson Involvement of vitamin D3 with cardiovascular function III. Effects on physical and morphological properties Am J Physiol 258 1990 E134 E142
77. B. Szab, B. Merkely, and I. Takcs The role of vitamin D in the development of cardiac failure [article in Hungarian] Orv Hetil 150 2009 1397 1402
78. R.J. McGonigle, M.B. Fowler, A.B. Timmis, M.J. Weston, and V. Parsons Uremic cardiomyopathy: potential role of vitamin D and parathyroid hormone Nephron 36 1984 94 100
79. E. Shane, D. Mancini, K. Aaronson, S.J. Silverberg, M.J. Seibel, V. Addesso, and D.J. McMahon Bone mass, vitamin D deficiency, and hyperparathyroidism in congestive heart failure Am J Med 103 1997 197 207
80. H. Bahrami, R. Kronmal, D.A. Bluemke, J. Olson, S. Shea, K. Liu, G.L. Burke, and J.A. Lima Differences in the incidence of congestive heart failure by ethnicity: the multi-ethnic study of atherosclerosis Arch Intern Med 168 2008 2138 2145
81. S.P. Laguardia, B.K. Dockery, S.K. Bhattacharya, M.D. Nelson, L.D. Carbone, and K.T. Weber Secondary hyperparathyroidism and hypovitaminosis D in African-Americans with decompensated heart failure Am J Med Sci 332 2006 112 118
82. S.S. Coughlin, L. Myers, and R.K. Michaels What explains black-white differences in survival in idiopathic dilated cardiomyopathy? The Washington, DC, Dilated Cardiomyopathy Study J Natl Med Assoc 89 1997 277 282
83. D.L. Dries, D.V. Exner, B.J. Gersh, H.A. Cooper, P.E. Carson, and M.J. Domanski Racial differences in the outcome of left ventricular dysfunction N Engl J Med 340 1999 609 616
84. V. Vaccarino, E. Gahbauer, S.V. Kasl, P.A. Charpentier, D. Acampora, and H.M. Krumholz Differences between African Americans and whites in the outcome of heart failure: Evidence for a greater functional decline in African Americans Am Heart J 143 2002 1058 1067
85. M.E. Reusser, D.B. DiRienzo, G.D. Miller, and D.A. McCarron Adequate nutrient intake can reduce cardiovascular disease risk in African Americans J Natl Med Assoc 95 2003 188 195
86. E. Hagstrom, P. Hellman, T.E. Larsson, E. Ingelsson, L. Berglund, J. Sundstrom, H. Melhus, C. Held, L. Lind, K. Michaelsson, and J. Arnlov Plasma parathyroid hormone and the risk of cardiovascular mortality in the community Circulation 119 2009 2765 2771
87. R. Luboshitzky, Y. Chertok-Schaham, I. Lavi, and A. Ishay Cardiovascular risk factors in primary hyperparathyroidism J Endocrinol Invest 32 2009 317 321
88. Yu N, T PD, Flynn Robert WV, Michael JM, Smith D, Rudman A, Graham PL. Increased mortality and morbidity in mild primary hyperparathyroid patients. Clin Endocrinol (Oxf). In press.
89. N.H. Bell, S. Epstein, A. Greene, J. Shary, M.J. Oexmann, and S. Shaw Evidence for alteration of the vitamin D-endocrine system in obese subjects J Clin Invest 76 1985 370 373
90. S. Alsafwah, S.P. Laguardia, M.D. Nelson, D.L. Battin, K.P. Newman, L.D. Carbone, and K.T. Weber Hypovitaminosis D in African Americans residing in Memphis, Tennessee with and without heart failure Am J Med Sci 335 2008 292 297
91. S. Nesby-O'Dell, K.S. Scanlon, M.E. Cogswell, C. Gillespie, B.W. Hollis, A.C. Looker, C. Allen, C. Doughertly, E.W. Gunter, and B.A. Bowman Hypovitaminosis D prevalence and determinants among African American and white women of reproductive age: Third National Health and Nutrition Examination Survey, 19881994 Am J Clin Nutr 76 2002 187 192
92. M. Wolf, J. Betancourt, Y. Chang, A. Shah, M. Teng, H. Tamez, O. Gutierrez, C.A. Camargo Jr, M. Melamed, K. Norris, M.J. Stampfer, N.R. Powe, and R. Thadhani Impact of activated vitamin D and race on survival among hemodialysis patients J Am Soc Nephrol 19 2008 1379 1388
93. A. Zittermann, S.S. Schleithoff, C. Gotting, O. Dronow, U. Fuchs, J. Kuhn, K. Kleesiek, G. Tenderich, and R. Koerfer Poor outcome in end-stage heart failure patients with low circulating calcitriol levels Eur J Heart Fail 10 2008 321 327
94. A. Testa, F. Mallamaci, F. Benedetto, A. Pisano, G. Tripepi, L. Malatino, R. Thadhani, and C. Zoccali Vitamin D receptor (VDR) gene polymorphism is associated with left ventricular (LV) mass and predicts LVH progression in end stage renal disease (ESRD) patients J Bone Miner Res 25 2009 313 319
95. C.W. Park, Y.S. Oh, Y.S. Shin, C.M. Kim, Y.S. Kim, S.Y. Kim, E.J. Choi, Y.S. Chang, and B.K. Bang Intravenous calcitriol regresses myocardial hypertrophy in hemodialysis patients with secondary hyperparathyroidism Am J Kidney Dis 33 1999 73 81
96. S.S. Schleithoff, A. Zittermann, G. Tenderich, H.K. Berthold, P. Stehle, and R. Koerfer Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: a double-blind, randomized, placebo-controlled trial Am J Clin Nutr 83 2006 754 759
97. C.B. Chavan, K. Sharada, H.B. Rao, and C. Narsimhan Hypocalcemia as a cause of reversible cardiomyopathy with ventricular tachycardia Ann Intern Med 146 2007 541 542
98. A.M. Vintzileos, S. Neckles, W.A. Campbell, J.W. Andreoli Jr, B.M. Kaplan, and D.J. Nochimson Three fetal ponderal indexes in normal pregnancy Obstet Gynecol 65 1985 807 811
99. S. Sood, R. Reghunandanan, V. Reghunandanan, K. Gopinathan, and A.K. Sood Effect of vitamin D deficiency on electrocardiogram of rats Indian J Exp Biol 33 1995 61 63
100. P. Autier, and S. Gandini Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials Arch Intern Med 167 2007 1730 1737